Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
批准号:
7197991
负责人:
THOMAS DOETSCHMAN
金额:
$36.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-15 至 2011-02-28
关键词:
Acquired Immunodeficiency SyndromeAddressAdoptive TransferAffectAntigensApoptosisArthritisAttenuatedAutoantigensAutoimmune DiseasesAutoimmune ProcessCalcineurinCalciumCancer VaccinesCell physiologyCellsCessation of lifeConditionContractsCultured CellsDependencyDevelopmentDiseaseDominant-Negative MutationEffector CellExhibitsGenerationsHandHomeostasisImmune ToleranceImmune systemIn VitroInflammationInflammatoryInsulin-Dependent Diabetes MellitusKnock-outLigandsLymphocyteLymphocyte ActivationMADH3 geneMaintenanceMature T-LymphocyteMediatingMolecularMouse StrainsMultiple SclerosisMusNatureNeoadjuvant TherapyNewborn InfantOvalbuminOvumPathway interactionsPeptidesPeripheralPlayPopulationPreventionProcessProductionRegulationResearch PersonnelRoleSelf ToleranceSignal PathwaySignal TransductionT cell regulationT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTransforming Growth Factor betaTransforming Growth FactorsTransgenic MiceTransgenic OrganismsTransplantationUpper armViralVirus Diseasesautocrinecell typecytokinehuman diseasein vivoleukemiaparacrinepathogenpreventprogramsreceptorresponsesizethymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary: T-cell homeostasis is an essential process for maintaining peripheral lymphocyte pool size. T cells must provide a diverse repertoire of antigen recognition to effectively recognize and destroy pathogens that they encounter. Antigen-specific T-cell pools are expanded during viral infection and are contracted after the initial viral clearance to make space for the entire T-cell repertoire. This is a tightly regulated process since the space available for lymphocytes is limited. Transforming Growth Factor ? signaling is required to prevent autoimmune disease and dysregulation of T-cell homeostasis. Normally, T cells must interact with self-MHC molecules for their survival, maintenance and homeostatic expansion, but under some pathological conditions such interactions cause inappropriate activation of T cells leading to autoimmune disease. Characterization of TGF??-deficient mice has revealed that their autoimmune disease results from spontaneous activation of their T cells in response to self-antigen recognition by having an inappropriately low threshold level of activation through a Calcium-Calcineurin signaling cascade. Elimination of T cells or their self-antigen recognition is sufficient to prevent autoimmune disease in these mice, and reducing calcineurin signaling drastically attenuates their autoimmune disease. In addition, it is known that without TGF? signaling there are less T-regulatory cells, the cells that mediate immune tolerance. Here we propose to investigate mechanisms and processes underlying the role of TGF? in the regulation of T-cell homeostasis and self-tolerance. Firstly, we will address how TGF?1 regulates T-cell pool size using an Ovalbumin-specific T-cell receptor transgenic TGF?1-deficient mouse strain. Adoptive transfer and Ovalbumin activation studies will be used. Secondly, we will study the role of TGF?? and its signaling pathways in peripheral T-cell regulation. T-regulatory cell transfer to effect tolerizing activity will be performed and the passive or infectious nature of that activity will be determined. Relevance: Dysregulation of homeostatic process has been implicated in many human diseases such as AIDS, leukemia, inflammatory bowl disease, and autoimmune diseases such as type 1 diabetes, multiple sclerosis and arthritis. Processes involved in T-cell homeostasis such as lymphocyte activation, survival and death are presently under intensive study because of their relevance to these diseases. The information gained from these studies will be useful for developing therapies for the induction of tolerance during transplantation, for enhancing tumor vaccine potential, and for the prevention of autoimmune disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell-specific analysis of transcription and epigenomic status in PDAC
-
批准号:8468670
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2012
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Cell-specific analysis of transcription and epigenomic status in PDAC
-
批准号:8227178
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2012
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Experimental Mice
-
批准号:7944527
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2009
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7492844
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7023314
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7759458
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
-
批准号:7775091
-
项目类别:
-
资助金额:$37.27万
-
财政年份:2006
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6623478
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6466184
-
项目类别:
-
资助金额:$37.94万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6729931
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Polymorphism Facility
-
批准号:6579909
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Modeling
-
批准号:6579908
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
-
批准号:6865395
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Modeling
-
批准号:6617326
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Polymorphism Facility
-
批准号:6618908
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Polymorphism Facility
-
批准号:6617327
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
Core--Mouse Modeling
-
批准号:6618907
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
CORE--MOUSE FACILITY
-
批准号:6346153
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
TUMOR SUPPRESSOR HETEROZYGOTES AS GENOTOXICANT REPORTERS
-
批准号:6346150
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
ANIMAL MODELS FOR CARDIOVASCULAR DISEASE
-
批准号:6202280
-
项目类别:
-
资助金额:$20.67万
-
财政年份:1999
-
负责人:THOMAS DOETSCHMAN
-
依托单位:
海外基金